c Candida infection has emerged as a critical health care burden worldwide, owing to the formation of robust biofilms against common antifungals. Recent evidence shows that multidrug-tolerant persisters critically account for biofilm recalcitrance, but their underlying biological mechanisms are poorly understood. Here, we first investigated the phenotypic characteristics of Candida biofilm persisters under consecutive harsh treatments of amphotericin B. The prolonged treatments effectively killed the majority of the cells of biofilms derived from representative strains of Candida albicans, Candida glabrata, and Candida tropicalis but failed to eradicate a small fraction of persisters. Next, we explored the tolerance mechanisms of the persisters through an investigation of the proteomic profiles of C. albicans biofilm persister fractions by liquid chromatography-tandem mass spectrometry. The C. albicans biofilm persisters displayed a specific proteomic signature, with an array of 205 differentially expressed proteins. The crucial enzymes involved in glycolysis, the tricarboxylic acid cycle, and protein synthesis were markedly downregulated, indicating that major metabolic activities are subdued in the persisters. It is noteworthy that certain metabolic pathways, such as the glyoxylate cycle, were able to be activated with significantly increased levels of isocitrate lyase and malate synthase. Moreover, a number of important proteins responsible for Candida growth, virulence, and the stress response were greatly upregulated. Interestingly, the persisters were tolerant to oxidative stress, despite highly induced intracellular superoxide. The current findings suggest that delicate metabolic control and a coordinated stress response may play a crucial role in mediating the survival and antifungal tolerance of Candida biofilm persisters. F ungal infections are a common and critical problem associated with extremely high morbidity and mortality rates, especially in immunocompromised individuals (1, 2). Candida species are the predominant pathogens in fungal infections, as they are part of normal human microbiota and are ubiquitous in the oral cavity, gastrointestinal tract, and skin of healthy individuals. Under particular conditions, these opportunistic pathogens might contribute to various superficial and even life-threatening systemic infections (3). It has been recognized that biofilm is the preferred mode of growth and existence for microorganisms, including Candida species, and Ն65% of human infections are attributed to biofilm formation and persistence (4). Biofilms attach to surfaces/interfaces and form by embedding themselves in a protective extracellular polymeric matrix. In particular, Candida species are notorious biofilm formers on indwelling medical devices, which is directly linked to therapeutic failure (3, 5). We and other groups have shown that Candida biofilms are highly resistant to antifungals (6, 7). Certain hypotheses have been made to elaborate on the mechanisms of increased antifungal resistanc...